Dysregulation of the host mevalonate pathway during early bacterial infection activates human TCR γδ cells
✍ Scribed by Magdalena Kistowska; Emmanuel Rossy; Sebastiano Sansano; Hans-Jürgen Gober; Regine Landmann; Lucia Mori; Gennaro De Libero
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 310 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Primates, but not rodents, have T cell receptor Vγ9‐Vδ2 T cells bridging innate and adaptive antimicrobial immunity. This T cell population is activated by prenyl pyrophosphates isolated from microbial or eukaryotic cells. Although the microbial metabolites are more active than the cellular ones, their involvement in TCR γδ activation during infection has not been studied. Here, we show that, during the initial phases of infections with Escherichia coli and Staphylococcus aureus, TCR γδ cells are activated by endogenous mevalonate metabolites. Infections with low bacteria inocula up‐regulate the production and accumulation of host‐derived TCR γδ stimulatory antigens within 1 h, which is followed by a peak of TCR γδ cell activation at 5 h. Infections induce the accumulation and dephosphorylation of the hydroxymethylglutaryl‐coenzyme A reductase, the rate‐limiting enzyme of the mevalonate pathway, resulting in increased activity of this enzyme and in increased synthesis of intermediate metabolites. Thus, primates have evolved the ability to readily respond to bacterial infection by sensing the dysregulation of the mevalonate pathway within infected cells, as a mechanism of immediate antimicrobial immunity.
Supporting Information for this article is available at http://www.wiley‐vch.de/contents/jc_2040/2008/38366_s.pdf